Carta Healthcare Secures $18.25 Million for AI-Powered Clinical Data Solutions
Carta Healthcare has secured $18.25 million in Series B1 funding to advance its AI-powered clinical data abstraction and analytics services, announced in a press release. The investment round was led by UPMC Enterprises, with participation from several strategic investors, including MemorialCare Innovation Fund and Rex Health Ventures.
The funding will enable Carta Healthcare to expand its customer base, particularly in the life sciences sector, and enhance its AI-driven solutions that streamline clinical data abstraction. This comes after the company's acquisition of Realyze Intelligence, which uses AI to analyze structured and unstructured data for clinical trials and research studies.
Brent Burns, Executive Vice President at UPMC Enterprises, highlighted the importance of Carta Healthcare's technology in addressing the challenges of clinical data abstraction and patient trial matching. The investment aims to support the company's mission to provide actionable insights that improve patient care and operational efficiency in healthcare systems.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer Bank Oct 16 KP Labs raises €4.42 million for AI data processing in orbit Oct 15 Origin Raises $20 Million for Autonomous Construction Robots Oct 15 Symbe Raises $5.7 Million for AI Sales PlatformMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsAI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Healthleap Raises $38 Million for Hospital Risk Screening AI
Healthcare Triangle Joins Kanzun-ARCB Fund to Connect Malaysian Companies With US Capital
Heidi Raises $340 Million for Health Care AI Expansion
Zivian Health Launches Elevate AI Chart Review Tool
CureMD Earns ISO/IEC 42001 Certification for AI Management
Daily AI Brief: the AI news that matters, in your inbox.